Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Public ClinicalTrials.gov record NCT00025727. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomized, Multicenter, Parallel Group, Open-Label, Three Arm Study to Compare the Efficacy and Safety of Two Dosing Regimens of GW433908/Ritonavir (700mg/100mg Twice Daily or 1400mg/200mg Once Daily) Versus Lopinavir/Ritonavir (400mg/100mg Twice Daily) for 48 Weeks in Protease Inhibitor Experienced HIV-Infected Adults Experiencing Virological Failure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to test 2 different dosing regimens of GW433908/ritonavir (RTV) versus lopinavir (LPV)/RTV when each is given with 2 active reverse transcriptase inhibitors (RTIs), in patients who have taken anti-HIV drugs without success.
Study identification
- NCT ID
- NCT00025727
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 330 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 13 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2001 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
Started 2001
United States locations
- U.S. sites
- 32
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix Body Positive | Phoenix | Arizona | 85006 | — |
| Ocean View Internal Medicine | Long Beach | California | 90803 | — |
| Bisher Akil | Los Angeles | California | 90046 | — |
| Tower ID Med Associates | Los Angeles | California | 90048 | — |
| Orange Coast Med Group | Newport Beach | California | 92663 | — |
| Pacific Horizons Med Group | San Francisco | California | 94115 | — |
| Denver Inf Disease Consultants | Denver | Colorado | 80220 | — |
| Physicans Home Service | Washington D.C. | District of Columbia | 20037 | — |
| IDC Research Initiative | Altamonte Springs | Florida | 32701 | — |
| Bach and Godofsky | Bradenton | Florida | 34205 | — |
| Community Health Care | Fort Lauderdale | Florida | 33306 | — |
| Therafirst Med Ctr | Fort Lauderdale | Florida | 33308 | — |
| North Broward Hosp District / HIV Clinical Research | Fort Lauderdale | Florida | 33311 | — |
| Florida ID Group | Orlando | Florida | 32801 | — |
| Discovery Alliance Inc | Pensacola | Florida | 32503 | — |
| West Florida Clinical Research Ctr | Pensacola | Florida | 32514 | — |
| Med College of Georgia | Augusta | Georgia | 30912 | — |
| Rush Med College / Dept of Infectious Diseases | Chicago | Illinois | 60612 | — |
| Boston Med Ctr / Evans - 556 | Boston | Massachusetts | 021182393 | — |
| Abbott-Northwestern Hosp / Clinic 42 | Minneapolis | Minnesota | 55404 | — |
| Southampton Healthcare Inc | St Louis | Missouri | 63139 | — |
| South Jersey Infectious Diseases Inc | Somers Point | New Jersey | 08244 | — |
| ID Care Inc | Somerville | New Jersey | 08876 | — |
| Garden State Infectious Diseases / E I P Kennedy Health Sys | Voorhees Township | New Jersey | 08043 | — |
| Gervais Frechette | New York | New York | 10011 | — |
| Duke Univ Med Ctr | Durham | North Carolina | 27710 | — |
| Summa Health System | Akron | Ohio | 44304 | — |
| Fanno Creek Clinic | Portland | Oregon | 97219 | — |
| Roger Williams Med Ctr | Providence | Rhode Island | 02908 | — |
| Methodist Healthcare | Memphis | Tennessee | 38104 | — |
| Joseph Gathe | Houston | Texas | 77004 | — |
| Virginia Commonwealth Univ | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00025727, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00025727 live on ClinicalTrials.gov.